Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A copy number gain on 18q present in primary prostate tumors is associated with metastatic outcome

Urologic Oncology Seminars and Original Investigations(2020)10.1016/j.urolonc.2020.06.015Source: DataRank Database

A copy number gain on 18q present in primary prostate tumors is associated with metastatic outcome is a research paper published in Urologic Oncology Seminars and Original Investigations (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.00)OA: greenTopics (47)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Teresa L. Johnson‐Pais ORCID,Dean A. Troyer ORCID,Javier Hernández ORCID,Robin J. Leach ORCID,Keith A. Ashcraft ORCID

Live enrichment

PubMed:32665124 PMC:PMC7996004 OpenAlex:https://openalex.org/W3041636842

National Cancer Institute

Grant: U01 CA086402

National Cancer Institute

Grant: P30 CA054174

Cancer Prevention and Research Institute of Texas

Grant: RP170345

Cancer Prevention and Research Institute of Texas

Grant: K12 GM111726

National Institutes of Health

Grant: 5P30CA054174-16

SAN ANTONIO CANCER INSTITUTE

National Institutes of Health

Grant: 3U01CA086402-02S1

SAN ANTONIO CENTER OF BIOMARKERS OF RISK FOR PROSTATE CA

National Institutes of Health

Grant: 1K12GM111726-01

San Antonio Biomedical Education and Research

NIH/NIGMS

FWCI

0.00

Citation Percentile

0.1%

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7996004

publisherhttps://api.elsevier.com/content/article/PII:S1078143920302854?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1078143920302854?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.urolonc.2020.06.015

Fields of Study

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentGenomic variations and chromosomal abnormalities0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

AdultAgedAged, 80 and overHumansMaleMiddle AgedNeoplasm MetastasisProstatectomyProstatic NeoplasmsDNA Copy Number Variations

Keywords

Comparative genomic hybridizationProstateProstate cancerProstatectomyImmunohistochemistryCopy-number variationChromosome 18Copy number analysisOncologyBiologyInternal medicineMedicinePathologyCancer researchChromosomeGeneCancerGenomeGeneticsOutcomeArray CghMalt1AdultAged, 80 and overMaleDNA Copy Number VariationsProstatic NeoplasmsMiddle AgedHumansNeoplasm MetastasisAged

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Peace, Justice and strong institutions

A copy number gain on 18q present in primary prostate tumors is associated with metastatic outcome

FAIR Checklist

Authors (5)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)